Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Zhejiang Starry Pharm Co Ltd

603520
Current price
9.42 CNY +0.37 CNY (+4.09%)
Last closed 9.15 CNY
ISIN CNE1000026N8
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Shanghai Stock Exchange
Capitalization 3 852 153 709 CNY
Yield for 12 month -42.46 %
1Y
3Y
5Y
10Y
15Y
603520
21.11.2021 - 28.11.2021

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products, such as levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is headquartered in Taizhou, China. Address: Modern Industrial Cluster Area, Taizhou, China, 317306

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

125.75 CNY

P/E ratio

96.6667

Dividend Yield

Current Year

+2 217 856 921 CNY

Last Year

+2 152 465 926 CNY

Current Quarter

+695 005 738 CNY

Last Quarter

+648 697 500 CNY

Current Year

+538 638 878 CNY

Last Year

+517 555 788 CNY

Current Quarter

+144 642 375 CNY

Last Quarter

+144 177 921 CNY

Key Figures 603520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 323 971 681 CNY
Operating Margin TTM 5.87 %
PE Ratio 96.6667
Return On Assets TTM 1.42 %
PEG Ratio
Return On Equity TTM 0.64 %
Wall Street Target Price 125.75 CNY
Revenue TTM 2 393 201 158 CNY
Book Value 4.62 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -13.3 %
Dividend Yield
Gross Profit TTM 517 555 787 CNY
Earnings per share 0.091 CNY
Diluted Eps TTM 0.091 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -65 %
Profit Margin 0.59 %

Dividend Analytics 603520

Dividend growth over 5 years

10 %

Continuous growth

Payout Ratio 5 years average

1 %

Dividend History 603520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 09.09.2024
Forward Annual Dividend Yield
Last Split Factor 1.4:1
Payout Ratio
Last Split Date 17.06.2022
Dividend Date

Stock Valuation 603520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 96.6667
Forward PE
Enterprise Value Revenue 2.275
Price Sales TTM 1.6392
Enterprise Value EBITDA 16.091
Price Book MRQ 1.4113

Financials 603520

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 603520

For 52 weeks

7.39 CNY 16.65 CNY
50 Day MA 8.63 CNY
Shares Short Prior Month
200 Day MA 10.47 CNY
Short Ratio
Shares Short
Short Percent